Optogenetics Market By Optogenetic tools (Light Equipment, Actuators, Sensors), By Application (Neuroscience, Retinal disorder, Behaviour tracking, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Description

List of Tables

According to a new report published by Allied Market Research, titled, "Optogenetics Market," The optogenetics market was valued at $114.1 million in 2022, and is estimated to reach $196.3 million by 2032, growing at a CAGR of 5.6% from 2023 to 2032. Optogenetics is a field of neuroscience that utilizes genetically modified light-sensitive cells and proteins called opsins to control neural activity using light. Opsins act as ion channels and can be activated by specific wavelengths of light, allowing precise and rapid manipulation of neurons. By selectively expressing opsins in targeted cells, researchers can study neural activity and behaviors. Optogenetics is used in animal models and can be used in development of new therapies for psychiatric and neurological disorders. It is a powerful tool that enables researchers to gain a deeper understanding of the complexities of the brain.

For instance, newly developed microbial opsins respond to different wavelengths of light, allowing researchers to target specific neurons with greater precision. Furthermore, development of novel opsins, laser sources, and imaging technologies to improve the effectiveness of optogenetic studies, further contribute toward the market growth.

In addition, development of highly efficient viral vectors for ocular gene therapy has led to new strategies for using optogenetic tools in vision restoration. Thus, advancement in optogenetic tools is driving the growth of the market. Moreover, increase in research activities for treating retinal diseases by using optogenetic tools further contribute toward the market growth. For instance, single intravitreal injection of virally-carried Multi-Characteristic Opsin (MCO-010) for the treatment of retinitis pigmentosa is under phase-2 evaluation. Thus, rise in the clinical evaluations is expected to create lucrative growth opportunities for optogenetics.

Furthermore, rise in funding activities to conduct the preclinical and clinical evaluations of new optogenetic applications by various government institutes further contribute toward the market growth. For instance, Institute for Auditory Neuroscience received funding of $2.6 million for its Cochlear Optogenetics for Auditory Research from December 2015 to February 2022 by the European Commission. Therefore, such initiatives taken by the government supports the institutes to continue the research of optogenetics, which, in turn, boosts the market growth.

However, factors that hinder the market growth include the high cost of laser sources and accessories. It further limits the adoption of optogenetics, which, in turn, restrains the market growth. For instance, Fabry-Perot Benchtop Laser Source, 405 nm, 8.0 mW, FC/PC offered by Thorlabs, Inc. costs about $1,900-$2,000. Thus, the high cost of laser sources negatively impact market growth.

On the other hand, increase in awareness about the potentials of optogenetics among researchers and wide applications of optogenetics in neuroscience research and drug discovery are expected to create immense opportunities for the optogenetics market during the forecast period.

The optogenetics market is segmented on the basis of optogenetic tools, application, and region. On the basis of optogenetic tools, the market is classified into light equipment, actuators, and sensors. As per application, the market is segmented into neuroscience, retinal disorders, behavior tracking, and others (cardiac, kidney injury, diabetic research, and others). Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global optogenetics market are Bruker Corporation, Coherent, Inc., Elliot Scientific Ltd., GenSight Biologics, Laserglow Technologies, Mightex, Prizmatix, Profacgen, Shanghai Laser & Optics Century Co., Ltd., and Thorlabs Inc.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the optogenetics market analysis from 2022 to 2032 to identify the prevailing optogenetics market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the optogenetics market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global optogenetics market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Optogenetic tools

Light Equipment
- Type
- LED
- LASER
Actuators
Sensors

By Application

Neuroscience
Retinal disorder
Behaviour tracking
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

Mightex
Prizmatix
Laserglow Technologies
Thorlabs Inc.
GenSight Biologics
Elliot Scientific Ltd.
Profacgen
Shanghai Laser & Optics Century Co., Ltd.
Coherent, Inc.
Bruker Corporation

Product Code: A10906

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Bargaining power of suppliers
- 3.3.2. Bargaining power of buyers
- 3.3.3. Threat of substitutes
- 3.3.4. Threat of new entrants
- 3.3.5. Intensity of rivalry
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Increase in demand for neuroscience research
  - 3.4.1.2. Technological advancement in optogenetics

3.4.2. Restraints
- 3.4.2.1. High cost of optogenetic tools

3.4.3. Opportunities
- 3.4.3.1. Increase in awareness about the potentials of optogenetics among researchers

3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: OPTOGENETICS MARKET, BY OPTOGENETIC TOOLS

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Light Equipment
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.2.4. Light Equipment Optogenetics Market by Type
4.3. Actuators
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Sensors
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country

CHAPTER 5: OPTOGENETICS MARKET, BY APPLICATION

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Neuroscience
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Retinal disorder
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Behaviour tracking
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
5.5. Others
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country

CHAPTER 6: OPTOGENETICS MARKET, BY REGION

6.1. Overview
- 6.1.1. Market size and forecast By Region
6.2. North America
- 6.2.1. Key trends and opportunities
- 6.2.2. Market size and forecast, by Optogenetic tools
- 6.2.3. Market size and forecast, by Application
- 6.2.4. Market size and forecast, by country
  - 6.2.4.1. U.S.
  - 6.2.4.1.1. Key market trends, growth factors and opportunities
  - 6.2.4.1.2. Market size and forecast, by Optogenetic tools
  - 6.2.4.1.3. Market size and forecast, by Application
  - 6.2.4.2. Canada
  - 6.2.4.2.1. Key market trends, growth factors and opportunities
  - 6.2.4.2.2. Market size and forecast, by Optogenetic tools
  - 6.2.4.2.3. Market size and forecast, by Application
  - 6.2.4.3. Mexico
  - 6.2.4.3.1. Key market trends, growth factors and opportunities
  - 6.2.4.3.2. Market size and forecast, by Optogenetic tools
  - 6.2.4.3.3. Market size and forecast, by Application
6.3. Europe
- 6.3.1. Key trends and opportunities
- 6.3.2. Market size and forecast, by Optogenetic tools
- 6.3.3. Market size and forecast, by Application
- 6.3.4. Market size and forecast, by country
  - 6.3.4.1. Germany
  - 6.3.4.1.1. Key market trends, growth factors and opportunities
  - 6.3.4.1.2. Market size and forecast, by Optogenetic tools
  - 6.3.4.1.3. Market size and forecast, by Application
  - 6.3.4.2. France
  - 6.3.4.2.1. Key market trends, growth factors and opportunities
  - 6.3.4.2.2. Market size and forecast, by Optogenetic tools
  - 6.3.4.2.3. Market size and forecast, by Application
  - 6.3.4.3. UK
  - 6.3.4.3.1. Key market trends, growth factors and opportunities
  - 6.3.4.3.2. Market size and forecast, by Optogenetic tools
  - 6.3.4.3.3. Market size and forecast, by Application
  - 6.3.4.4. Italy
  - 6.3.4.4.1. Key market trends, growth factors and opportunities
  - 6.3.4.4.2. Market size and forecast, by Optogenetic tools
  - 6.3.4.4.3. Market size and forecast, by Application
  - 6.3.4.5. Spain
  - 6.3.4.5.1. Key market trends, growth factors and opportunities
  - 6.3.4.5.2. Market size and forecast, by Optogenetic tools
  - 6.3.4.5.3. Market size and forecast, by Application
  - 6.3.4.6. Rest of Europe
  - 6.3.4.6.1. Key market trends, growth factors and opportunities
  - 6.3.4.6.2. Market size and forecast, by Optogenetic tools
  - 6.3.4.6.3. Market size and forecast, by Application
6.4. Asia-Pacific
- 6.4.1. Key trends and opportunities
- 6.4.2. Market size and forecast, by Optogenetic tools
- 6.4.3. Market size and forecast, by Application
- 6.4.4. Market size and forecast, by country
  - 6.4.4.1. Japan
  - 6.4.4.1.1. Key market trends, growth factors and opportunities
  - 6.4.4.1.2. Market size and forecast, by Optogenetic tools
  - 6.4.4.1.3. Market size and forecast, by Application
  - 6.4.4.2. China
  - 6.4.4.2.1. Key market trends, growth factors and opportunities
  - 6.4.4.2.2. Market size and forecast, by Optogenetic tools
  - 6.4.4.2.3. Market size and forecast, by Application
  - 6.4.4.3. Australia
  - 6.4.4.3.1. Key market trends, growth factors and opportunities
  - 6.4.4.3.2. Market size and forecast, by Optogenetic tools
  - 6.4.4.3.3. Market size and forecast, by Application
  - 6.4.4.4. India
  - 6.4.4.4.1. Key market trends, growth factors and opportunities
  - 6.4.4.4.2. Market size and forecast, by Optogenetic tools
  - 6.4.4.4.3. Market size and forecast, by Application
  - 6.4.4.5. South Korea
  - 6.4.4.5.1. Key market trends, growth factors and opportunities
  - 6.4.4.5.2. Market size and forecast, by Optogenetic tools
  - 6.4.4.5.3. Market size and forecast, by Application
  - 6.4.4.6. Rest of Asia-Pacific
  - 6.4.4.6.1. Key market trends, growth factors and opportunities
  - 6.4.4.6.2. Market size and forecast, by Optogenetic tools
  - 6.4.4.6.3. Market size and forecast, by Application
6.5. LAMEA
- 6.5.1. Key trends and opportunities
- 6.5.2. Market size and forecast, by Optogenetic tools
- 6.5.3. Market size and forecast, by Application
- 6.5.4. Market size and forecast, by country
  - 6.5.4.1. Brazil
  - 6.5.4.1.1. Key market trends, growth factors and opportunities
  - 6.5.4.1.2. Market size and forecast, by Optogenetic tools
  - 6.5.4.1.3. Market size and forecast, by Application
  - 6.5.4.2. Saudi Arabia
  - 6.5.4.2.1. Key market trends, growth factors and opportunities
  - 6.5.4.2.2. Market size and forecast, by Optogenetic tools
  - 6.5.4.2.3. Market size and forecast, by Application
  - 6.5.4.3. South Africa
  - 6.5.4.3.1. Key market trends, growth factors and opportunities
  - 6.5.4.3.2. Market size and forecast, by Optogenetic tools
  - 6.5.4.3.3. Market size and forecast, by Application
  - 6.5.4.4. Rest of LAMEA
  - 6.5.4.4.1. Key market trends, growth factors and opportunities
  - 6.5.4.4.2. Market size and forecast, by Optogenetic tools
  - 6.5.4.4.3. Market size and forecast, by Application

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

8.1. GenSight Biologics
- 8.1.1. Company overview
- 8.1.2. Key Executives
- 8.1.3. Company snapshot
- 8.1.4. Operating business segments
- 8.1.5. Product portfolio
- 8.1.6. Business performance
8.2. Bruker Corporation
- 8.2.1. Company overview
- 8.2.2. Key Executives
- 8.2.3. Company snapshot
- 8.2.4. Operating business segments
- 8.2.5. Product portfolio
- 8.2.6. Business performance
- 8.2.7. Key strategic moves and developments
8.3. Coherent, Inc.
- 8.3.1. Company overview
- 8.3.2. Key Executives
- 8.3.3. Company snapshot
- 8.3.4. Operating business segments
- 8.3.5. Product portfolio
- 8.3.6. Business performance
8.4. Mightex
- 8.4.1. Company overview
- 8.4.2. Key Executives
- 8.4.3. Company snapshot
- 8.4.4. Operating business segments
- 8.4.5. Product portfolio
8.5. Profacgen
- 8.5.1. Company overview
- 8.5.2. Key Executives
- 8.5.3. Company snapshot
- 8.5.4. Operating business segments
- 8.5.5. Product portfolio
8.6. Laserglow Technologies
- 8.6.1. Company overview
- 8.6.2. Key Executives
- 8.6.3. Company snapshot
- 8.6.4. Operating business segments
- 8.6.5. Product portfolio
8.7. Thorlabs Inc.
- 8.7.1. Company overview
- 8.7.2. Key Executives
- 8.7.3. Company snapshot
- 8.7.4. Operating business segments
- 8.7.5. Product portfolio
8.8. Shanghai Laser & Optics Century Co., Ltd.
- 8.8.1. Company overview
- 8.8.2. Key Executives
- 8.8.3. Company snapshot
- 8.8.4. Operating business segments
- 8.8.5. Product portfolio
8.9. Elliot Scientific Ltd.
- 8.9.1. Company overview
- 8.9.2. Key Executives
- 8.9.3. Company snapshot
- 8.9.4. Operating business segments
- 8.9.5. Product portfolio
8.10. Prizmatix
- 8.10.1. Company overview
- 8.10.2. Key Executives
- 8.10.3. Company snapshot
- 8.10.4. Operating business segments
- 8.10.5. Product portfolio